Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDApplied DNA Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2025 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Applied DNA Sciences, Inc. Earnings Date And Information
Applied DNA Sciences, Inc. last posted its earnings results on Thursday, February 13th, 2025. The company reported $-0.56 earnings per share for the quarter, missing analysts' consensus estimates of $-0.32 by $0.24. The company had revenue of 1.20 M for the quarter and had revenue of 3.43 M for the year. Applied DNA Sciences, Inc. has generated $-2 earnings per share over the last year ($-1.76 diluted earnings per share) and currently has a price-to-earnings ratio of -0.2. Applied DNA Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.
Applied DNA Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/13/2025 | Q1 2025 | -$0.32 | -$0.08 | 0.24 | $1.04 M | $1.20 M |
| 12/17/2024 | Q4 2024 | -$0.33 | -$0.19 | 0.14 | $899,000 | $813,107 |
| 08/08/2024 | Q3 2024 | -$0.35 | $0.47 | 0.82 | $1.08 M | $797,519 |
| 05/10/2024 | Q2 2024 | -$4.60 | -$5.13 | -0.53 | N/A | $929,631 |
| 02/08/2024 | Q1 2024 | -$6.20 | -$1.80 | 4.4 | $776,000 | $891,164 |
| 01/26/2024 | Q4 2023 | N/A | -$5.29 | N/A | $1.68 M | $779,736 |
| 08/10/2023 | Q3 2023 | -$4.80 | -$4.80 | 0 | $2.56 M | $2.92 M |
| 05/11/2023 | Q2 2023 | -$3.40 | $0.91 | 4.31 | N/A | $4.41 M |
| 02/09/2023 | Q1 2023 | -$6.60 | -$6.00 | 0.6 | N/A | $5.26 M |
| 01/27/2023 | Q4 2022 | N/A | -$1.37 | N/A | $4.10 M | $3.56 M |
| 08/11/2022 | Q3 2022 | -$7.20 | -$2.32 | 4.88 | $3.60 M | $4.30 M |
| 05/12/2022 | Q2 2022 | -$6.00 | -$2.79 | 3.21 | N/A | $6.15 M |
| 02/10/2022 | Q1 2022 | -$3.80 | -$12.61 | -8.81 | N/A | $4.17 M |
| 01/28/2022 | Q4 2021 | N/A | -$12.04 | N/A | $2.30 M | $3.04 M |
| 08/12/2021 | Q3 2021 | -$4.80 | -$9.53 | -4.73 | $3.13 M | $1.70 M |
| 05/13/2021 | Q2 2021 | -$3.60 | -$4.19 | -0.59 | N/A | $2.67 M |
| 02/11/2021 | Q1 2021 | -$11.00 | -$17.62 | -6.62 | N/A | $1.62 M |
| 12/17/2020 | Q4 2020 | -$11.80 | -$16.04 | -4.24 | $707,500 | $313,989 |
| 08/06/2020 | Q3 2020 | -$12.40 | -$14.37 | -1.97 | $802,000 | $431,516 |
| 05/14/2020 | Q2 2020 | -$0.77 | -$15.71 | -14.94 | N/A | $552,473 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Applied DNA Sciences, Inc. Earnings: FAQ's
Applied DNA Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based offlast year's report dates.
The conference call for Applied DNA Sciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Applied DNA Sciences, Inc.'s latest earnings report can be read online.
Applied DNA Sciences, Inc. (:APDN) has a recorded annual revenue of $3.43 M.
Applied DNA Sciences, Inc. (:APDN) has a recorded net income of $-6,992,521.Applied DNA Sciences, Inc. has generated $-1.76 earnings per share over the last four quarters.
Applied DNA Sciences, Inc. (:APDN) has a price-to-earnings ratio of -0.2 and price/earnings-to-growth ratio is -0.01.